نتایج جستجو برای: gist tumor

تعداد نتایج: 430446  

2016
Sung Jin Oh Byoung Jo Suh Jong Kwon Park

A schwannoma is a kind of neurogenic tumor that rarely occurs in the gastrointestinal tract. Gastric schwannomas make up 0.2% of all gastric neoplasms. Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors and up to 60-70% of GIST occur in the stomach. Schwannoma and GIST are similar in clinical features, so they are difficult to differentiate preoperatively. Differentia...

2016
Chih-Min Tang Tracy E. Lee Sabriya A. Syed Adam M. Burgoyne Stephanie Y. Leonard Fei Gao Jonathan C. Chan Eileen Shi Juliann Chmielecki Deborah Morosini Kai Wang Jeffrey S. Ross Michael L. Kendrick Michael R. Bardsley Martina De Siena Junhao Mao Olivier Harismendy Tamas Ordog Jason K. Sicklick

Gastrointestinal stromal tumors (GIST) arise within the interstitial cell of Cajal (ICC) lineage due to activating KIT/PDGFRA mutations. Both ICC and GIST possess primary cilia (PC), which coordinate PDGFRA and Hedgehog signaling, regulators of gastrointestinal mesenchymal development. Therefore, we hypothesized that Hedgehog signaling may be altered in human GIST and controls KIT expression. Q...

2013
Badreddin Edris Stephen Willingham Kipp Weiskopf Anne K Volkmer Jens-Peter Volkmer Thomas Mühlenberg Irving L Weissman Matt van de Rijn

Acquired resistance to imatinib is a significant problem for the clinical management of gastrointestinal stromal tumor (GIST) patients, and second-line small molecules have shown limited efficacy in this setting. We have recently demonstrated that a monoclonal antibody targeting KIT could potentially bypass imatinib resistance in preclinical models of GIST.

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Giuseppe Floris Agnieszka Wozniak Raf Sciot Haifu Li Lori Friedman Thomas Van Looy Jasmien Wellens Peter Vermaelen Christophe M Deroose Jonathan A Fletcher Maria Debiec-Rychter Patrick Schöffski

PURPOSE Oncogenic signaling in gastrointestinal stromal tumors (GIST) is sustained via PI3K/AKT pathway. We used a panel of six GIST xenograft models to assess efficacy of GDC-0941 as single agent or in combination with imatinib (IMA). EXPERIMENTAL DESIGN Nude mice (n = 136) were grafted bilaterally with human GIST carrying diverse KIT mutations. Mice were orally dosed over four weeks, groupe...

2015
Mai Isosaka Takeshi Niinuma Masanori Nojima Masahiro Kai Eiichiro Yamamoto Reo Maruyama Takayuki Nobuoka Toshirou Nishida Tatsuo Kanda Takahiro Taguchi Tadashi Hasegawa Takashi Tokino Koichi Hirata Hiromu Suzuki Yasuhisa Shinomura Ramanjulu Sunkar

BACKGROUND Dysregulation of microRNA (miRNA) has been implicated in gastrointestinal stromal tumors (GISTs) but the mechanism is not fully understood. In this study, we aimed to explore the involvement of epigenetic alteration of miRNA genes in GISTs. METHODS GIST-T1 cells were treated with 5-aza-2'-deoxycytidine (5-aza-dC) and 4-phenylbutyric acid (PBA), after which miRNA expression profiles...

Journal: :The journal of medical investigation : JMI 2002
Takayuki Miyauchi Masashi Ishikawa Masanori Nisioka Yutaka Kashiwagi Hisatsugu Miki Yasunori Sato Noriko Endo Takashige Uemura Shuji Inoue Makoto Hiroi Touru Kikutsuji Naoko Ohgami

An 85-year-old woman was admitted to our hospital because of vomiting. An upper gastrointestinal series what showed a large esophageal hiatus hernia, suggesting an association with extrinsic pressure in the middle portion of the stomach. An upper gastrointestinal endoscopic examination showed severe esophagitis and a prominent narrowing in the middle portion of the stomach, however, it showed n...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Agnieszka Wozniak Piotr Rutkowski Patrick Schöffski Isabelle Ray-Coquard Isabelle Hostein Hans-Ulrich Schildhaus Axel Le Cesne Elzbieta Bylina Janusz Limon Jean-Yves Blay Janusz A Siedlecki Eva Wardelmann Raf Sciot Jean-Michel Coindre Maria Debiec-Rychter

PURPOSE Although the mutational status in gastrointestinal stromal tumors (GIST) can predict the response to treatment with tyrosine kinase inhibitors, the role of tumor genotype as a prognostic factor remains controversial. The ConticaGIST study sought to determine the pathologic and molecular factors associated with disease-free survival (DFS) in patients with operable, imatinib-naive GIST. ...

Journal: :European journal of breast health 2017
Bermal Hasbay Hüseyin Özgür Aytaç Fazilet Kayaselçuk Neşe Torun

Gastrointestinal Stromal Tumors (GIST) are the common mesenchymal tumors of gastrointestinal tract. They can display benign and malignant clinical behavior. The most common metastasis sites of malignant stromal tumor are liver, peritoneum, lung and bones. Metastasis to breast is extremely rare. Here, we present a case of GIST with liver, bone, lymph node and breast metastasis by reviewing the l...

Journal: :Chang Gung medical journal 2008
King-Fair Hall Chia-Li Lin Tsung-Hsi Wang Rung-Ho Chang Han-Ming Chen

Gastrointestinal stromal tumor (GIST) is an uncommon malignant tumor that has recently been drawn to the attention of clinicians because of the protean clinical spectrum, endocrinological pathogenesis, aggressive metastatic features, poor prognosis, oncogenic tyrosine kinase receptor mutation and its brilliant revolutionized inhibitor imatinib. However, very few cases of GIST and hypoglycemia h...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2015
Zhan-De He Xin-En Huang Jian-Nong Zhou

BACKGROUND To investigate the diagnostic and treatment methods for Chinese patients with gastrointestinal stromal tumor (GIST). MATERIALS AND METHODS From January 2004 to June 2014, patients diagnosed with primary GIST and treated by a single medical team in the Department of Digestive Disease of XuYi Hospital of Traditional Chinese Medicine were retrospectively recruited. Re-examination and ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید